An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation

The Family Smoking Prevention and Tobacco Control Act of 2009 gave the Food and Drug Administration (FDA) regulatory authority over cigarettes and smokeless tobacco products and authorised it to assert jurisdiction over other tobacco products. As with other Federal agencies, FDA is required to asses...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Tob Control
Päätekijät: Chaloupka, Frank J, Warner, Kenneth E, Acemoğlu, Daron, Gruber, Jonathan, Laux, Fritz, Max, Wendy, Newhouse, Joseph, Schelling, Thomas, Sindelar, Jody
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2015
Aiheet:
Special Communication
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4345832/
https://ncbi.nlm.nih.gov/pubmed/25550419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tobaccocontrol-2014-052022
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia